{"id":6141,"date":"2023-08-31T15:32:46","date_gmt":"2023-08-31T19:32:46","guid":{"rendered":"https:\/\/health.uconn.edu\/neuroscience\/?p=6141"},"modified":"2023-08-31T15:40:30","modified_gmt":"2023-08-31T19:40:30","slug":"counteract-nih-translational-grant-awarded-to-the-mohan-lab","status":"publish","type":"post","link":"https:\/\/health.uconn.edu\/neuroscience\/2023\/08\/31\/counteract-nih-translational-grant-awarded-to-the-mohan-lab\/","title":{"rendered":"CounterACT NIH Translational Grant Awarded to the Mohan lab"},"content":{"rendered":"<p>The eye is one of the most sensitive organs that can be injured by toxic chemicals and warfare agents, but drug treatments to mitigate chemical-induced ocular pathology have not been developed. \u00a0Alerted to increased threats posed by homeland terrorists who could cause mass casualty by chemical exposure, the trans NIH-agency CounterACT program was developed to fund cutting-edge research to combat bodily injury (<a href=\"https:\/\/www.ninds.nih.gov\/current-research\/trans-agency-activities\/counteract-program\" rel=\"\">https:\/\/www.ninds.nih.gov\/current-research\/trans-agency-activities\/counteract-program<\/a>.)\u00a0 Dr. Mohan is a recipient of a National Eye Institute grant titled \u201cUnraveling the corneal and retinal mechanisms of chemical injury\u201d to expand his research on novel therapeutic targets in the eye for such chemical emergencies.<\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/health.uconn.edu\/neuroscience\/wp-content\/uploads\/sites\/121\/2023\/08\/Team-Mohan.jpg\"><img loading=\"lazy\" decoding=\"async\" data-src=\"https:\/\/health.uconn.edu\/neuroscience\/wp-content\/uploads\/sites\/121\/2023\/08\/Team-Mohan-300x229.jpg\" alt=\"team Mohan\" width=\"300\" height=\"229\" class=\"alignnone size-medium wp-image-6142 lazyload\" data-srcset=\"https:\/\/health.uconn.edu\/neuroscience\/wp-content\/uploads\/sites\/121\/2023\/08\/Team-Mohan-300x229.jpg 300w, https:\/\/health.uconn.edu\/neuroscience\/wp-content\/uploads\/sites\/121\/2023\/08\/Team-Mohan.jpg 607w\" data-sizes=\"(max-width: 300px) 100vw, 300px\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" style=\"--smush-placeholder-width: 300px; --smush-placeholder-aspect-ratio: 300\/229;\" \/><noscript><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/health.uconn.edu\/neuroscience\/wp-content\/uploads\/sites\/121\/2023\/08\/Team-Mohan-300x229.jpg\" alt=\"team Mohan\" width=\"300\" height=\"229\" class=\"alignnone size-medium wp-image-6142\" srcset=\"https:\/\/health.uconn.edu\/neuroscience\/wp-content\/uploads\/sites\/121\/2023\/08\/Team-Mohan-300x229.jpg 300w, https:\/\/health.uconn.edu\/neuroscience\/wp-content\/uploads\/sites\/121\/2023\/08\/Team-Mohan.jpg 607w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/noscript><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The eye is one of the most sensitive organs that can be injured by toxic chemicals and warfare agents, but drug treatments to mitigate chemical-induced ocular pathology have not been developed. \u00a0Alerted to increased threats posed by homeland terrorists who could cause mass casualty by chemical exposure, the trans NIH-agency CounterACT program was developed to [&hellip;]<\/p>\n","protected":false},"author":2772,"featured_media":6142,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wds_primary_category":0,"footnotes":""},"categories":[3,4,5],"tags":[],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-26 05:32:23","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/posts\/6141"}],"collection":[{"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/users\/2772"}],"replies":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/comments?post=6141"}],"version-history":[{"count":1,"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/posts\/6141\/revisions"}],"predecessor-version":[{"id":6143,"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/posts\/6141\/revisions\/6143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/media\/6142"}],"wp:attachment":[{"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/media?parent=6141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/categories?post=6141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/health.uconn.edu\/neuroscience\/wp-json\/wp\/v2\/tags?post=6141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}